Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2012; 18(19): 2357-2363
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2357
Figure 1
Figure 1 Percentages of respondents with sensitivity > 80% according to availability of rapid on-site cytopathology evaluation (rapid on-site cytopathological evaluation) of endoscopic ultrasonography-guided fine needle aspiration samples. The number above each bar represents the total number of respondents in each category. For example, among 10 respondents who had ROSE available in selected cases, five (50%) self-reported a sensitivity > 80% for the diagnosis of solid mass lesions. EUS-FNA: Endoscopic ultrasonography-guided fine needle aspiration; ROSE: Rapid on-site cytopathological evaluation.
Figure 2
Figure 2 Percentages of respondents with sensitivity > 80% according to annual hospital caseload. The number above each bar represents the total number of respondents in each category. For example, among 20 respondents with an annual hospital caseload < 50 EUS-FNA, three (15.0%) self-reported a sensitivity > 80% for the diagnosis of solid mass lesions. EUS-FNA: Endoscopic ultrasonography-guided fine needle aspiration.